Long-term use of ticagrelor in patients with prior myocardial infarction.

P Bonaca, Marc; L Bhatt, Deepak; Cohen, Marc; Gabriel Steg, Philippe; F Storey, Robert; C Jensen, Eva; Magnani, Giulia; Bansilal, Sameer; Polly Fish, M; Im, Kyungah; Bengtsson, Olof; Oude Ophuis, Ton; Budaj, Andrzej; Theroux, Pierre; Ruda, Mikhail; Hamm, Christian; Goto, Shinya; Spinar, Jindrich; Carlos Nicolau, José; G Kiss, Robert; A Murphy, Sabina; D Wiviott, Stephen; Held, Peter; Braunwald, Eugene; S Sabatine, Marc; 54 Steering Committee and Investigators, PEGASUS-TIMI

doi:10.1056/NEJMoa1500857

Public

Long-term use of ticagrelor in patients with prior myocardial infarction.

Shared by NobleBlocks on May 7, 2015 • 12:00 AM UTC

Authors:

Marc P Bonaca

Deepak L Bhatt

Marc Cohen

Abstract

BACKGROUND: The potential benefit of dual antiplatelet therapy beyond 1 year after a myocardial infarction has not been established. We investigated the efficacy and safety of ticagrelor, a P2Y12 receptor antagonist with established efficacy after an acute coronary syndrome, in this context. METHODS...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!